Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections

Journal of Clinical Microbiology

Volumn 48, Issue 4, 2010, Pages 1428-1431

  Cremniter, Julie ^a,b   Slassi, Asma ^d   Quincampoix, Jean Charles ^d   Sivadon Tardy, Valérie ^a,b   Bauer, Thomas ^c   Porcher, Raphaël ^f   Lortat Jacob, Alain ^c   Piriou, Philippe ^e   Judet, Thierry ^e   Herrmann, Jean Louis ^a,d   Gaillard, Jean Louis ^a,b,d   Rottman, Martin ^a,d,e  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b Laboratoire de Microbiologie   (France)

^c Chirurgie Orthopédique et Traumatologie   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

^e RAYMOND POINCARÉ HOSPITAL   (France)

^f SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BONE INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEVICE INFECTION; FEMALE; HUMAN; INFECTIOUS ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORTHOPEDIC EQUIPMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; SURGICAL TECHNIQUE;

STAPHYLOCOCCUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 77950508075     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02098-09     Document Type: Article

References (25)

1. Atkins, B. L., N. Athanasou, J. J. Deeks, D. W. Crook, H. Simpson, T. E. Peto, P. McLardy-Smith, and A. R. Berendt. 1998. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. The OSIRIS Collaborative Study Group. J. Clin. Microbiol. 36:2932-2939.
2. Bertrand, X., S. Lallemand, M. Thouverez, K. Boisson, and D. Talon. 2002. Bacteremia caused by coagulase-negative staphylococci: incidence, frequency of teicoplanin resistance and molecular epidemiology. Pathol. Biol. (Paris) 50:552-559.
3. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard. CLSI publication no. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2009. Communiqué 2009. Société Française de Microbiologie, Paris, France.
5. Eliopoulos, G. M. 2009. Microbiology of drugs for treating multiply drugresistant Gram-positive bacteria. J. Infect. 59(Suppl. 1):S17-S24.
6. Ferreira, R. B., N. L. Iorio, K. L. Malvar, A. P. Nunes, L. S. Fonseca, C. C. Bastos, and K. R. Santos. 2003. Coagulase-negative staphylococci: comparison of phcnotypic and genotypic oxacillin susceptibility tests and evaluation of the agar screening test by using different concentrations of oxacillin. J. Clin. Microbiol. 41:3609-3614.
7. Gazzola, S., and P. S. Cocconcelli. 2008. Vancomycin heteroresistance and biofilm formation in Staphylococcus epidermidis from food. Microbiology 154:3224-3231.
8. Maniati, M., E. Petinaki, Kontos, A. N. Maniatis, I. Spiliopoulou, D. Petropoulou-Mylonu, H. Malamou-Lada, L. Spaliara, and C. Koutsia-Carouzou. 2005. Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece. Int. J. Antimicrob. Agents 25:346-348.
9. Murakami, K., W. Minamide, K. Wada, E. Nakamura, H. Teraoka, and S. Watanabe. 1991, Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29:2240-2244.
10. Nunes, A. P., L. M. Teixeira, N. L. Iorio, C. C. Bastos, L. de Sousa Fonseca, T. Souto-Padron, and K. R. dos Santos. 2006. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical, strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening. Int. J. Antimicrob. Agents 27: 307-3.15.
11. Paragioudaki, M., V. Stamouli, F. Kolonitsiou, E. D. Anastassiou, G. Dimitracopoulos, and I. Spiliopoulou. 2004. Intravenous catheter infections associated with bacteraemia: a 2-year study in a university hospital. Clin. Microbiol. Infect. 10:431-435.
12. Phillips, J. E., T. P. Crane, M. Noy, T. S. Elliott, and R. J. Grimer. 2006. The Incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J. Bone Joint Surg. Br. 88:943-948.
13. Siebert, W. T., N. Moreland, and T. W. Williams, Jr. 1979. Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis. J. Infect. Dis. 139:452-457.
14. Sieradzki, K., R. B. Roberts, S. W. Haber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
15. Sieradzki, K., P. Villari, and A. Tomasz. 1998. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42:100-107.
16. Sivadon, V., M. Rottman, S. Chaverot, J. C. Quincampoix, V. Avettand, P. de Mazancourt, L. Bernard, P. Trieu-Cuot, J. M. Feron, A. Lortat-Jacob, P. Piriou, T. Judet, and J. L. Gaillard. 2005. Use of genotypic identification by sodA sequencing in a prospective study to examine the distribution of coagulase-negative Staphylococcus species among strains recovered during septic orthopedic surgery and evaluate their significance. J. Clin. Microbiol. 43: 2952-2954.
17. Sivadon, V., M. Rottman, J. C. Quincampoix, V. Avettand, S. Chaverot, P. de Mazancourt, P. Trieu-Cuot, and J. L. Gaillard. 2004. Use of sodA sequencing for the Identification of clinical isolates of coagulase-negative staphylococci. Clin. Microbiol. Infect. 10:939-942.
18. Smith, T. L., M. L. Pearson, K. R. Wilcox, C. Cruz, M. V. Lancaster, B. Robinson-Dunn, F. C. Tenover, M. J. Zervos, J. D. Band, E. White, and W. R. Jarvis. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N. Engl. J. Med. 340:493-501.
19. Srinivasan, A., J. D. Dick, and T. M. Perl. 2002. Vancomycin resistance in staphylococci. Clin. Microbiol. Rev. 15:430-438.
20. Stefani, S., and P. E. Varaldo. 2003. Epidemiology of methicillin-resistant staphylococci in Europe. Clin. Microbiol. Infect. 9:1179-1186.
21. Tacconelli, E., M. Tumbarello, K. G. Donati, M. Bettio, T. Spanu, F. Leone, L. A. Sechi, S. Zanetti, G. Fadda, and R. Cauda. 2001, Glycopeptide resistance among coagulase-negative staphylococci that cause bacteremia: epidemiological and clinical findings from a case-control study. Clin. Infect. Dis. 33:1628-1635.
22. Trampuz, A., K. E. Piper, M. J. Jacobson, A. D. Hanssen, K. K. Unni, D. R. Osmon, J. N. Mandrekar, F. R. Cockerill, J. M. Steckelberg, J. F. Greenleaf, and R. Patel. 2007. Sonication of removed hip and knee prostheses for diagnosis of infection. N. Engl, J. Med. 357:654-663.
23. Trampuz, A., and W. Zimmerli. 2005. New strategies for the treatment of infections associated with prosthetic joints. Curr. Opin. Investig. Drugs 6:185-190.
24. Trueba, F., E. Garrabe, R. Hadef, R. Fabre, J. D. Cavallo, K. Tsvetkova, and O. Chesneau. 2006. High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study. J. Clin. Microbiol. 44:1922-1923.
25. von EUf, C., G. Peters, and C. Heilmann. 2002. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect. Dis. 2:677-685.